Company Filing History:
1 out of 1,778 
1 out of 99 
Years Active: 2023
Title: Nicole Alexis Spiegelman: Innovator in Genetic Research
Introduction
Nicole Alexis Spiegelman is a prominent inventor based in Somerville, MA (US). She has made significant contributions to the field of genetic research, particularly in the area of nuclear receptor expression. Her innovative work has the potential to impact the treatment of various diseases and disorders.
Latest Patents
Nicole holds a patent for "Compositions and methods for inhibiting nuclear receptor subfamily 1 group H member 3 (NR1H3) expression." This patent includes oligonucleotides that inhibit NR1H3 expression. Additionally, it provides compositions and their uses, particularly in treating diseases, disorders, and conditions associated with NR1H3 expression.
Career Highlights
Throughout her career, Nicole has worked with notable companies such as Novo Nordisk A/S and Dicerna Pharmaceuticals, Inc. Her experience in these organizations has allowed her to develop her expertise in genetic research and innovation.
Collaborations
Nicole has collaborated with talented individuals in her field, including Utsav Saxena and Henryk T. Dudek. These collaborations have further enriched her research and contributed to her success as an inventor.
Conclusion
Nicole Alexis Spiegelman is a trailblazer in genetic research, with a focus on inhibiting NR1H3 expression. Her innovative patent and collaborations highlight her commitment to advancing medical science.